ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
02/18/2026
Back to search
Official data from USPTO
T315I MUTATION TREATMENT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
79
Latest update
04/03/2026
Trademark type
Combined
Nice classes
42, 44
Filing date
01/15/2021
Registration date
09/02/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/02/2025
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
3
Owner type
11
Owner location
SAINT-LAURENT, CA
Examiner
KNIGHT, TROY FRANK
Law office
L70
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of grey letters and numbers for "T315I" with the "3" being a swirl design where the outside is purple and the inside is orange and the words "MUTATION TREATMENT" are in purple title case letters with a purple plus sign in front of these words.
Holders and representatives
Holders
KNIGHT THERAPEUTICS INC.
ENDO OPERATIONS LIMITED
Paladin Labs Inc.
Representatives
Camille M. Miller COZEN O'CONNOR
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Providing scientific analysis and informational reports based upon results of laboratory testing in the field of kinase inhibitor treatment failuregeneticsepigenetics and cancer; Scientific research in the fields of kinase inhibitor treatment failuregeneticsepigenetics and cancer; Laboratory research in the field of the field of cancer researchkinase inhibitor treatment failuregenetics; Providing laboratory research services in the field of kinase inhibitor treatment failure and genetic testing
Class 44
Medical testing for diagnostic and prognostic purposes in the field of cancerkinase inhibitor treatment failuregenetics; Medical testing for diagnostic and treatment purposes in the field of cancer researchkinase inhibitor treatment failure researchgenetics research; Providing medical information to medical professionalsoncologists and treating physicians for cancer patientsin the form of reports in the field of cancer diagnostics and prognostics; Medical testing serviceskinase inhibitor treatment failure and genetic testing for diagnosis and treatment of cancer; Genetic testing for medical purposes
Publications
History of USPTO decisions and trademark events.
79 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/02/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
09/02/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/15/2025
PUBO
PUBLISHED FOR OPPOSITION
07/15/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/09/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/13/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/02/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/02/2025
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
06/02/2025
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
04/19/2025
GNSL
LETTER OF SUSPENSION E-MAILED
04/19/2025
CNSL
SUSPENSION LETTER WRITTEN
04/19/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/11/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/11/2025
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
04/08/2025
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
02/12/2025
GNSI
INQUIRY TO SUSPENSION E-MAILED
02/12/2025
CNSI
SUSPENSION INQUIRY WRITTEN
02/12/2025
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
02/04/2025
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
06/28/2024
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
06/17/2024
GNSL
LETTER OF SUSPENSION E-MAILED
06/17/2024
CNSL
SUSPENSION LETTER WRITTEN
06/17/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/24/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/24/2024
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
05/24/2024
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
05/23/2024
GNSI
INQUIRY TO SUSPENSION E-MAILED
05/23/2024
CNSI
SUSPENSION INQUIRY WRITTEN
05/23/2024
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
05/03/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
05/01/2024
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
02/21/2024
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
08/20/2023
GNSL
LETTER OF SUSPENSION E-MAILED
08/20/2023
CNSL
SUSPENSION LETTER WRITTEN
08/20/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/10/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/10/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
06/09/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
06/08/2023
GNSL
LETTER OF SUSPENSION E-MAILED
06/08/2023
CNSL
SUSPENSION LETTER WRITTEN
06/08/2023
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
04/06/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
09/07/2022
GNSL
LETTER OF SUSPENSION E-MAILED
09/07/2022
CNSL
SUSPENSION LETTER WRITTEN
09/07/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/26/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/26/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
08/25/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
08/24/2022
GNSL
LETTER OF SUSPENSION E-MAILED
08/24/2022
CNSL
SUSPENSION LETTER WRITTEN
08/24/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
07/29/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/29/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
07/29/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/29/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/11/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/11/2022
ALIE
ASSIGNED TO LIE
07/10/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
06/24/2022
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
06/22/2022
GNSI
INQUIRY TO SUSPENSION E-MAILED
06/22/2022
CNSI
SUSPENSION INQUIRY WRITTEN
06/22/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
06/21/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
06/01/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
10/27/2021
GNSL
LETTER OF SUSPENSION E-MAILED
10/27/2021
CNSL
SUSPENSION LETTER WRITTEN
10/27/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/18/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/17/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/17/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/16/2021
GNRT
NON-FINAL ACTION E-MAILED
08/16/2021
CNRT
NON-FINAL ACTION WRITTEN
08/16/2021
DOCK
ASSIGNED TO EXAMINER
07/27/2021
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
04/17/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/16/2021
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
04/14/2021
NWAP
NEW APPLICATION ENTERED
01/19/2021
Continuous trademark protection
Get notified about every new filing that threatens T315I MUTATION TREATMENT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.